Related News
China negotiates on patented, imported drugs, prices to halve
Online Edition
THE National Health and Family Planning Commission is negotiating with pharmaceutical companies on lowering prices of five drugs as part of a pilot program, said Li Bin, head of the commission, on Tuesday.
The five drugs are for treatment of cancer or other major diseases, and are very expensive as they are patented or imported, Li said, adding that their prices are expected to be cut by at least half.
Li, who was speaking at the press conference on the sidelines of the annual parliamentary session, did not elaborate on which drugs or pharmaceutical companies are involved.
Once negotiations are concluded successfully, the drugs can be covered by health insurance, added Ma Xiaowei, the commission's deputy.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
